Nana Hsiang-Hua Wang1, Shih-Jen Chen2, Chi-Fan Yang3, Hui-Wen Chen3, Hui-Ping Chuang3, Yung-Hsiu Lu4, Chien-Hsiun Chen3, Jer-Yuarn Wu3, Dau-Ming Niu4, Yuan-Tsong Chen3. 1. Molecular Medicine Program Taiwan International Graduate Program, Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan 2Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan 3Institute of Biochemistry and Molecular Biology, School. 2. Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan 5School of Medicine, National Yang-Ming University, Taipei, Taiwan. 3. Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan. 4. Department of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan 7Institute of Clinical Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
Abstract
PURPOSE: To identify the genetic cause in five families with autosomal recessive retinitis pigmentosa, a genetic disorder involving retinal degeneration and visual loss with high genetic heterogeneity. METHODS: We performed whole-genome single nucleotide polymorphism genotyping on 35 members from the five families to map the region of homozygosity shared by all patients. Whole-genome sequencing was then conducted on one of the patients and a novel variant was identified in POMGNT1 from the homozygous region, which was confirmed by Sanger sequencing and sequenced in all family members. Mutant and wild-type POMGNT1 were expressed in heterologous cells to assess enzyme activity. RESULTS: A 1.8-Mb homozygous region was identified at 1p34-p33 shared by all 17 patients. Whole-genome sequencing revealed a novel missense mutation in POMGNT1 (c.359A>C, p.Leu120Arg) from this homozygous region, which was shown to co-segregate with disease phenotype. The mutant protein carrying this missense mutation showed an approximately 80% decrease in POMGNT1 enzyme activity compared with the wild type. CONCLUSIONS: We identified a novel mutation in POMGNT1 that causes nonsyndromic autosomal recessive retinitis pigmentosa, adding to the genetic heterogeneity of this retinal disease. POMGNT1 encodes a glycosyltransferase in O-mannosyl glycosylation and was previously found to be responsible for a group of congenital muscular dystrophies called dystroglycanopathies. Our discovery suggests the involvement of O-mannosyl glycosylation in retinitis pigmentosa and presents an instance of POMGNT1 mutation that does not involve muscular dystrophy.
PURPOSE: To identify the genetic cause in five families with autosomal recessive retinitis pigmentosa, a genetic disorder involving retinal degeneration and visual loss with high genetic heterogeneity. METHODS: We performed whole-genome single nucleotide polymorphism genotyping on 35 members from the five families to map the region of homozygosity shared by all patients. Whole-genome sequencing was then conducted on one of the patients and a novel variant was identified in POMGNT1 from the homozygous region, which was confirmed by Sanger sequencing and sequenced in all family members. Mutant and wild-type POMGNT1 were expressed in heterologous cells to assess enzyme activity. RESULTS: A 1.8-Mb homozygous region was identified at 1p34-p33 shared by all 17 patients. Whole-genome sequencing revealed a novel missense mutation in POMGNT1 (c.359A>C, p.Leu120Arg) from this homozygous region, which was shown to co-segregate with disease phenotype. The mutant protein carrying this missense mutation showed an approximately 80% decrease in POMGNT1 enzyme activity compared with the wild type. CONCLUSIONS: We identified a novel mutation in POMGNT1 that causes nonsyndromic autosomal recessive retinitis pigmentosa, adding to the genetic heterogeneity of this retinal disease. POMGNT1 encodes a glycosyltransferase in O-mannosyl glycosylation and was previously found to be responsible for a group of congenital muscular dystrophies called dystroglycanopathies. Our discovery suggests the involvement of O-mannosyl glycosylation in retinitis pigmentosa and presents an instance of POMGNT1 mutation that does not involve muscular dystrophy.
Authors: Hasenin Al-Khersan; Kaanan P Shah; Segun C Jung; Alex Rodriguez; Ravi K Madduri; Michael A Grassi Journal: Graefes Arch Clin Exp Ophthalmol Date: 2017-05-01 Impact factor: 3.117
Authors: Ana B Garcia-Delgado; Lourdes Valdes-Sanchez; Maria Jose Morillo-Sanchez; Beatriz Ponte-Zuñiga; Francisco J Diaz-Corrales; Berta de la Cerda Journal: Orphanet J Rare Dis Date: 2021-05-17 Impact factor: 4.123
Authors: Song Liu; Jian Gang Bi; Yunlong Hu; Donge Tang; Bo Li; Peng Zhu; Wujian Peng; Dong Du; Huiyan He; Jun Zeng; Yong Dai Journal: Mol Genet Genomic Med Date: 2019-02-20 Impact factor: 2.183
Authors: Valeria Lo Faro; Ilja M Nolte; Jacoline B Ten Brink; Harold Snieder; Nomdo M Jansonius; Arthur A Bergen Journal: Front Genet Date: 2021-12-16 Impact factor: 4.599